Bernd G Stegmayr
Overview
Explore the profile of Bernd G Stegmayr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stegmayr B, Lundberg L
BMC Nephrol
. 2024 Jul;
25(1):223.
PMID: 38997655
Background: Cardiovascular diseases are the dominant cause of morbidity in hemodialysis (HD) patients. Unless sufficient anticoagulation is used during HD, clotting may appear. The objective was to investigate if levels...
2.
Groth T, Stegmayr B, Ash S, Kuchinka J, Wieringa F, Fissell W, et al.
Artif Organs
. 2022 Sep;
47(4):649-666.
PMID: 36129158
Background: Chronic kidney disease (CKD) is a major cause of early death worldwide. By 2030, 14.5 million people will have end-stage kidney disease (ESKD, or CKD stage 5), yet only...
3.
Goto J, Forsberg U, Jonsson P, Matsuda K, Nilsson B, Nilsson Ekdahl K, et al.
Int J Artif Organs
. 2020 Dec;
44(8):539-550.
PMID: 33339470
Aims: To investigate if a single low-flux HD induces a rise in cardiac biomarkers and if a change in clinical approach may limit such mechanism. Material And Methods: A total...
4.
Nilsson C, Sperker W, Schien C, Isaksson M, Stegmayr B
Int J Artif Organs
. 2019 Oct;
43(4):225-228.
PMID: 31648577
Aim: When performing acute onset dialysis after insertion of catheters for peritoneal dialysis, pain exists and tunnel infections may develop. This study investigated whether patients benefit from the use of...
5.
Vollmer T, Ljungberg B, Jankowski V, Jankowski J, Glorieux G, Stegmayr B
Sci Rep
. 2019 Oct;
9(1):14525.
PMID: 31601841
Identifying the key toxic players within an in-vivo toxic syndrome is crucial to develop targeted therapies. Here, we established a novel method that characterizes the effect of single substances by...
6.
Mahmood D, Stegmayr B
Blood Purif
. 2018 Jul;
46(3):257-263.
PMID: 29972824
Anticoagulation with citrate-containing haemodialysate (cHD) is an alternative to tinzaparin haemodialysate (tHD). The study investigated whether cHD would differ when changed from tHD. The same 18 patients were their own...
7.
Skagerlind M, Stegmayr B
Eur J Clin Pharmacol
. 2017 Dec;
74(3):267-274.
PMID: 29198062
Introduction: Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of...
8.
Stegmayr B
Semin Dial
. 2016 Aug;
29(6):442-446.
PMID: 27528100
Patients on chronic hemodialysis have a shortened survival compared to the general population. There are multiple sources of morbidity and mortality unique to the dialysis population that account for this....
9.
Stegmayr B, Sperker W, Nilsson C, Degerman C, Persson S, Stenbaek J, et al.
Medicine (Baltimore)
. 2015 Dec;
94(48):e2083.
PMID: 26632891
We developed a technique for direct start of peritoneal dialysis. Using a coiled or straight Tenckhoff catheter often results in obstruction of flow. A self-locating Wolfram catheter is on the...
10.
Stegmayr B, Jonsson P, Mahmood D
Int J Artif Organs
. 2013 Jan;
36(1):1-6.
PMID: 23280073
Background: The blood membrane interaction induced during hemodialysis (HD) activates the coagulation system. To prevent clotting and to maintain dialyzer patency, an anticoagulant such as tinzaparin is used. To increase...